Should statins be continued in patients who are already receiving them at the time of dialysis initiation?
Yes, we suggest that these agents be continued in patients already receiving statins or statin/ezetimibe combination at the time of dialysis initiation. However, physicians should consider periodically reviewing the clinical status of dialysis patients and revisiting the decision to prescribe statins as required. Discontinuation of statin or statin/ezetimibe may be warranted in patients who place a relatively low value on a small potential relative reduction in cardiovascular events, and a relatively high value on the risks of polypharmacy and drug toxicity.